Patents Assigned to Poppy Health, Inc.
  • Patent number: 12181401
    Abstract: One variation of a method includes, during execution of a tracer test: triggering release of a tracer load into air in an aerosol zone by a dispenser transiently arranged in the aerosol zone, the tracer load including a concentration of aerosol tracers; and recording a timeseries of aerosol data via a sensor unit transiently arranged in the aerosol zone, the timeseries of aerosol data representing concentrations of aerosol particles present in air. The method further includes: based on the timeseries of aerosol data and the concentration, deriving a tracer concentration curve representing change in concentration of aerosol tracer particles; based on characteristics of the tracer concentration curve, deriving an airflow value representing removal of aerosol particles from the aerosol zone during the tracer test; and interpreting an outcome for the tracer test based on a difference between the airflow value and a target airflow value defined for the aerosol zone.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: December 31, 2024
    Assignee: Poppy Health, Inc.
    Inventors: Kalyan Kottapalli, Sam Molyneux, Konrad Swic, Elizabeth Caley, Aaron Botham
  • Patent number: 11733252
    Abstract: One variation of a method includes, during a calibration period: triggering collection of an initial bioaerosol sample by an air sampler located in an environment; and triggering dispensation of a tracer test load by a dispenser located in the environment; accessing a detected barcode level of a barcode detected in the initial bioaerosol sample; accessing a true barcode level of the barcode contained in the tracer test load; and deriving a calibration factor for the environment based on a difference between the detected barcode level and the true barcode level. The method further includes, during a live period succeeding the calibration period: triggering collection of a first bioaerosol sample by the air sampler; accessing a detected pathogen level of a pathogen detected in the first bioaerosol sample; and interpreting a predicted pathogen level of the pathogen in the environment based on the detected pathogen level and the calibration factor.
    Type: Grant
    Filed: November 29, 2022
    Date of Patent: August 22, 2023
    Assignee: Poppy Health, Inc.
    Inventors: Sam D. Molyneux, Elizabeth Caley, Daniela Bezdan, Ricardo Vidal, Nathan Volman, Tae Joon Yi, Kevin Slavin
  • Patent number: 11597980
    Abstract: One variation of a pathogen detection system includes an air sampler and a cartridge. The air sampler includes: a housing defining an inlet and an outlet; a tunnel arranged within the housing and extending between the inlet and the outlet; a charge electrode arranged within the tunnel proximal the inlet; a cartridge receptacle arranged proximal the outlet and comprising a cartridge terminal; and a power supply configured to drive a voltage between the charge electrode and the cartridge terminal. The cartridge includes: a substrate; a collector plate arranged on the substrate and configured to collect charged bioaerosols moving through the tunnel; and a connector configured to transiently engage the cartridge receptacle to locate the substrate and the collector plate within the tunnel and electrically couple the collector plate to the cartridge terminal.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: March 7, 2023
    Assignee: Poppy Health, Inc.
    Inventors: Sam D. Molyneux, Elizabeth Caley, Daniela Bezdan, Ricardo Vidal, Nathan Volman, Tae Joon Yi
  • Patent number: 11543332
    Abstract: One variation of a method includes, during a calibration period: triggering collection of an initial bioaerosol sample by an air sampler located in an environment; and triggering dispensation of a tracer test load by a dispenser located in the environment; accessing a detected barcode level of a barcode detected in the initial bioaerosol sample; accessing a true barcode level of the barcode contained in the tracer test load; and deriving a calibration factor for the environment based on a difference between the detected barcode level and the true barcode level. The method further includes, during a live period succeeding the calibration period: triggering collection of a first bioaerosol sample by the air sampler; accessing a detected pathogen level of a pathogen detected in the first bioaerosol sample; and interpreting a predicted pathogen level of the pathogen in the environment based on the detected pathogen level and the calibration factor.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: January 3, 2023
    Assignee: Poppy Health, Inc.
    Inventors: Sam D. Molyneux, Elizabeth Caley, Daniela Bezdan, Ricardo Vidal, Nathan Volman, Tae Joon Yi, Kevin Slavin
  • Patent number: 11519040
    Abstract: One variation of a method for detecting pathogens in an environment includes, during a first sampling period: triggering collection of a pathogen sample from ambient air in the environment by an air sampler; and tracking a first organic load of the first pathogen sample via a detection subsystem integrated within the air sampler, the first organic load representative of a first amount of organic matter present in the first pathogen sample. In response to the first organic load exceeding a threshold organic load defined for the environment, the method further includes: interpreting presence of a set of pathogens in the environment via genetic analysis of the first pathogen sample; and, in response to detecting presence of a first pathogen, in the set of pathogens, in the first pathogen sample, transmitting a notification indicating presence of the first pathogen in the environment to a user associated with the environment.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: December 6, 2022
    Assignee: Poppy Health, Inc.
    Inventors: Sam D. Molyneux, Elizabeth Caley, Daniela Bezdan, Ricardo Vidal, Nathan A. Volman, Tae Joon Yi